WCM
DGX icon

Winton Capital Management’s Quest Diagnostics DGX Stock Holding History

Winton Capital Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		$33.6M Buy
579,700
+341,233
+143% +$18.3M 0.23% 181
2013
Q4 		$12.8M Buy
238,467
+111,012
+87% +$6.58M 0.11% 281
2013
Q3 		$7.88M Sell
127,455
-111,992
-47% -$6.7M 0.09% 304
2013
Q2 		$14.5M Buy
+239,447
New +$14.3M 0.18% 207

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
AAM
Aberdeen Asset Management Aberdeen, United Kingdom $30B AUM 22.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Winton Capital Management's DGX Position: Q1 2014 in Review

Winton Capital Management increased its Quest Diagnostics (DGX) stake by 143% in Q1 2014, buying an estimated $18.3M and bringing the position to 579,700 shares worth $33.6M. The position accounts for 0.23% of the portfolio, ranked #181.

Winton Capital Management first reported a position in DGX in Q2 2013 and has held it in 4 quarters since. 491 funds tracked by Wall St. Rank hold DGX as of Q1 2014.

  • Winton Capital Management held 579,700 shares of Quest Diagnostics worth $33.6M as of Q1 2014.
  • Winton Capital Management bought 341,233 Quest Diagnostics shares in Q1 2014, an estimated $18.3M.
  • Quest Diagnostics made up 0.23% of Winton Capital Management's portfolio in Q1 2014, its #181 holding.
  • Winton Capital Management first reported a position in Quest Diagnostics in Q2 2013 and has held it in 4 quarters since.
  • 491 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2014.

Based on Winton Capital Management's 13F filing for Q1 2014, filed 1 May 2014.